LEADER 00761nam0-22003011i-450 001 990000863570403321 005 20191114092047.0 010 $a0-672-30168-7 035 $a000086357 035 $aFED01000086357 035 $a(Aleph)000086357FED01 035 $a000086357 100 $a20001010d1992----km-y0itay50------ba 101 0 $aeng 105 $ay-------001yy 200 1 $aAdvanced C$fP. D. Hipson 210 $aCarmel$cSAMS Publishing$d1992 215 $aXXV, 777 p.$d23 cm 676 $a005.1 700 1$aHipson,$bPeter D.$042704 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990000863570403321 952 $a02 51 C 51$b6845$fFINBN 959 $aFINBN 996 $aAdvanced C$9349124 997 $aUNINA DB $aING01 LEADER 02124oam 2200649I 450 001 9910706169303321 005 20170825125338.0 035 $a(CKB)5470000002454732 035 $a(OCoLC)858255342 035 $a(EXLCZ)995470000002454732 100 $a20130912j199905 ua 0 101 0 $aeng 135 $aurbn||||a|a|| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAeroacoustic data for a high Reynolds number axisymmetric subsonic jet /$fMichael K. Ponton, Lawrence S. Ukeiley, Sang W. Lee 210 1$aHampton, Virginia :$cNational Aeronautics and Space Administration, Langley Research Center,$dMay 1999. 215 $a1 online resource (84 pages) $cillustrations 225 1 $aNASA/TM ;$v1999-209336 300 $a"May 1999." 300 $a"Performing organization: NASA Langley Research Center"--Report documentation page. 320 $aIncludes bibliographical references (page 5). 606 $aAeroacoustics$2nasat 606 $aConvergent nozzles$2nasat 606 $aJet flow$2nasat 606 $aSubsonic flow$2nasat 606 $aHigh Reynolds number$2nasat 606 $aPressure oscillations$2nasat 606 $aFlow characteristics$2nasat 606 $aEngine noise$2nasat 606 $aExhaust nozzles$2nasat 606 $aExhaust gases$2nasat 615 7$aAeroacoustics. 615 7$aConvergent nozzles. 615 7$aJet flow. 615 7$aSubsonic flow. 615 7$aHigh Reynolds number. 615 7$aPressure oscillations. 615 7$aFlow characteristics. 615 7$aEngine noise. 615 7$aExhaust nozzles. 615 7$aExhaust gases. 700 $aPonton$b Michael K.$01416815 702 $aUkeiley$b Lawrence S. 702 $aLee$b Sang W. 712 02$aLangley Research Center, 801 0$bOCLCE 801 1$bOCLCE 801 2$bOCLCO 801 2$bOCLCF 801 2$bOCLCQ 801 2$bGPO 906 $aBOOK 912 $a9910706169303321 996 $aAeroacoustic data for a high Reynolds number axisymmetric subsonic jet$93523467 997 $aUNINA LEADER 03851nam 2200805z- 450 001 9910639987503321 005 20231214133546.0 010 $a3-0365-6090-4 035 $a(CKB)5470000001633479 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/95822 035 $a(EXLCZ)995470000001633479 100 $a20202301d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aCOVID-19 and Gastrointestinal Disease: Current Insights and Future Management 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 electronic resource (184 p.) 311 $a3-0365-6089-0 330 $aCOVID-19 is the most prominent and rapidly evolving public health concern in the world currently. The gastrointestinal manifestations of COVID-19 are increasingly being recognized. SARS-CoV-2 infection has been associated with the occurrence of nausea, vomiting, and diarrhea. SARS-CoV-2 has also been causing pancreatic and hepatic injury. Emerging data have shown that COVID-19 patients continue to shed the virus into their stools, even when patients test negative for COVID-19 in pulmonary secretions. However, the epidemiology, pathogenesis, and treatment of SARS-CoV-2-related gastrointestinal manifestations are poorly understood. The pandemic has also had a significant impact on gastroenterologists, endoscopists, and other ancillary staff. Moreover, in the past, systematic respiratory virus syndrome (SARS) was shown to be transmitted by endoscopes, which is a big concern with COVID-19, as it shares many pathological features with SARS. The deferral of elective endoscopic procedures has negatively affected gastroenterologists. This Special Issue focuses on the current situation of this pandemic. It aims to provide insight into the gastrointestinal manifestations of COVID-19 and its effects on endoscopic procedures. I believe that this issue will be beneficial not only for gastroenterologists but also other healthcare workers around the world to recognize the often-ignored clinical gastrointestinal manifestations of COVID-19. 517 $aCOVID-19 and Gastrointestinal Disease 606 $aMedicine$2bicssc 610 $aCOVID-19 610 $aliver 610 $anon-alcoholic steatohepatitis 610 $atransient elastography 610 $amortality 610 $aliver disease 610 $aclinical manifestations 610 $aSARS-CoV-2 610 $agastroenterology 610 $ahepatology 610 $aendoscopy 610 $adelivery of healthcare 610 $aacute mesenteric ischemia 610 $athromboemboembolism 610 $aendothelitis 610 $acytokines 610 $ahypercoagulability 610 $ainflammatory bowel disease 610 $agastrointestinal manifestations 610 $aabdominal pain 610 $adyspnea 610 $aclinical course 610 $aupper gastrointestinal bleeding 610 $apandemic 610 $aoutcomes 610 $aanxiety 610 $adepression 610 $amedication adherence 610 $aseverity of COVID-19 610 $ahospitalized patients 610 $arisk factors 610 $aSARS-CoV-2 infection 610 $agut dysbiosis 610 $amicrobiota 610 $agastrointestinal disorders 610 $aintestinal inflammation 610 $aACE2 dysregulation 610 $agut microbiota 610 $aenteric infection 615 7$aMedicine 700 $aGoyal$b Hemant$4edt$01279880 702 $aGoyal$b Hemant$4oth 906 $aBOOK 912 $a9910639987503321 996 $aCOVID-19 and Gastrointestinal Disease: Current Insights and Future Management$93016105 997 $aUNINA